Regeneron Pharmaceuticals
REGN
#247
Rank
ยฃ58.12 B
Marketcap
ยฃ531.71
Share price
-3.99%
Change (1 day)
-29.90%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): ยฃ30.36

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is ยฃ28.81. In 2022 the company made an earnings per share (EPS) of ยฃ31.25 a decrease over its 2021 EPS that were of ยฃ58.96.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ30.36-2.83%
2022ยฃ31.25-47%
2021ยฃ58.96133.36%
2020ยฃ25.2669.13%
2019ยฃ14.94-14.44%
2018ยฃ17.46100.71%
2017ยฃ8.7031.78%
2016ยฃ6.6038.96%
2015ยฃ4.7572.55%
2014ยฃ2.75-17.55%
2013ยฃ3.34-44.98%
2012ยฃ6.07-422.54%
2011-ยฃ1.8892.13%
2010-ยฃ0.9849.41%
2009-ยฃ0.66-15.84%
2008-ยฃ0.78-36.88%
2007-ยฃ1.23-9.6%
2006-ยฃ1.364.12%
2005-ยฃ1.31-323.68%
2004ยฃ0.59-135.51%
2003-ยฃ1.65-24.38%
2002-ยฃ2.1856.35%
2001-ยฃ1.40187.3%
2000-ยฃ0.49-16%
1999-ยฃ0.58177.78%
1998-ยฃ0.21-35.71%
1997-ยฃ0.32-68.42%
1996-ยฃ1.03

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ยฃ10.91-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ3.17-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ14.24-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ10.86-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.88-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
ยฃ2.45-91.49%๐Ÿ‡ซ๐Ÿ‡ท France